Research programme: hepatocyte growth factor kringle fragments - EntreMed
Alternative Names: K2-3; NK1-3Latest Information Update: 13 Jul 2007
At a glance
- Originator EntreMed
- Class
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 13 Jul 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 03 Sep 2003 This project is available for licensing (http://www.entremed.com)
- 03 Apr 2001 Preclinical development for Cancer in USA (unspecified route)